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Introduction
cAMP and cGMP are second messengers that play
important roles in intracellular signal transduction of
various external stimuli. Major functions of both are the
activation of cAMP-dependent protein kinase A (PKA)
and cGMP-dependent protein kinase G (PKG), respec-
tively. PKA and PKG are members of the serine-threo-
nine protein kinase superfamily and are involved in the
control of various cellular processes.
PKA exists as an inactive tetramer of two regulatory
(R) and two catalytic (C) subunits that dissociate in the
presence of cAMP [1]. PKG is a polypeptide composed
of a regulatory domain which contains two tandem
cGMP–binding sites that interact allosterically and a
catalytic domain [2]. Binding of cGMP to the regulatory
domain increases the phosphotransferase activity of
PKG.
Besides cAMP and cGMP, other cyclic nucleotides can
tentatively function as second messengers. As shown by
Desch et al. [3], the membrane-permeable cCMP-analo-
gue dibutyryl-cCMP induces smooth muscle relaxation
and activates PKGI in aortic tissue lysates by using the
cGMP signal transduction pathway. Therefore, we have
searched for further binding proteins by using cCMP-
agaroses and cCMP-capture compounds, and we have
identified the regulatory subunits of PKA as cCMP-
interacting proteins.
Methods
PKA kinase activity with the regulatory subunits RIa
and RIIa of PKA and PKGIa kinase activity were
measured by in-vitro kinase assays in the presence of
different cyclic nucleotides and analogues.
Results and discussion
We discovered that besides the known activators cAMP
and cGMP, also all other cyclic nucleotides (cNMPs)
studied (cCMP, cIMP, cUMP and cXMP) activate RIa
and RIIa, but with distinct activation constants (EC50),
different Hill slopes and different maximal effects
(Emax). The most potent activator for RIa and RIIa was
cAMP. For RIa the Hill slopes indicated positive coop-
erativity for binding of all cNMPs, most notably for
cAMP and cIMP. For RIa the most efficacious nucleo-
tide was cIMP; for RIIa the most effective activator was
cUMP.
For PKGIa the most potent and effective activator was
cGMP. All other cNMPs (cAMP, cCMP and cUMP) stu-
died could also activate the enzyme, but the EC50 values
and efficacies were much lower. For PKGIa we found a
higher specificity for the cognate cNMP in comparison
to PKA RIa and RIIa.
By using membrane-permeable butyryl-cNMPs as acti-
vators, we found that only the mono-butyrylated cNMPs
activated RIa and RIIa of PKA. Monobutyryl (mb)-
cCMP was a more potent activator for RIa and RIIa in
comparison to cCMP with a higher maximal activity for
RIa. The Hill slopes for the activation of RIa with
cCMP and mb-cCMP showed positive cooperativity.
To achieve substrate-specificity, A-kinase-anchoring
proteins (AKAPs) bind to the regulatory subunits. In
further studies the influence of different cNMPs on
AKAP binding will be determined.
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Table 1 LogEC50 and Emax values for the activation of RIa
(a), RIIa (b) and PKGIa (c) with cNMPs
A
cAMP cIMP cGMP cCMP cUMP cXMP
LogEC50[M] -7.1 -5.9 -4.9 -4.4 -4.2 -3.5
Emax 1.00 1.09 1.06 1.04 1.04 1.00
B
cAMP cIMP cGMP cCMP cUMP cXMP
LogEC50[M] -7.0 -5.4 -4.5 -4.0 -4.4 -3.2
Emax 1.00 1.07 1.07 1.23 1.26 1.07
C
cGMP cAMP cCMP cUMP
LogEC50 [M] -7.0 -5.0 -4.9 -4.1
Emax 1.00 0.46 0.56 0.71
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